本页面由Tiger Trade Technology Pte. Ltd.提供服务

Akari Therapeutics PLC

5.12
+0.510011.06%
盘后4.83-0.2853-5.57%19:59 EDT
成交量:1.31万
成交额:6.47万
市值:586.00万
市盈率:-0.25
高:5.27
开:4.61
低:4.61
收:4.61
52周最高:63.20
52周最低:3.25
股本:114.45万
流通股本:86.33万
量比:1.09
换手率:1.52%
股息:- -
股息率:- -
每股收益(TTM):-20.5537
每股收益(LYR):-20.5537
净资产收益率:-68.43%
总资产收益率:-15.36%
市净率:0.21
市盈率(LYR):-0.25

数据加载中...

2020/02/14

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/01/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/23

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/02

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/11/27

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/24

SEC问询函

[Cover]Correspondence
2019/10/15

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/15

招股说明书

Registration statement for certain foreign private issuers
2019/10/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/10/04

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/09/13

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/09/06

SEC问询函

[Cover]Correspondence
2019/08/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/30

[修订]招股说明书

[Amend] Registration statement for certain foreign private issuers
2019/08/29

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/08/19

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2019/08/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]